Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | BLM | P54132 | 2/20 | 0.48 |
| ▸ | RECQL | P46063 | 2/20 | 0.48 |
| ▸ | TSHR | P16473 | 2/20 | 0.48 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.48 |
| ▸ | POLB | P06746 | 2/20 | 0.48 |
| ▸ | CYP2C19 | P33261 | 2/20 | 0.48 |
| ▸ | F2 | P00734 | 1/20 | 0.48 |
| ▸ | F10 | P00742 | 1/20 | 0.48 |
| ▸ | F12 | P00748 | 1/20 | 0.48 |
| ▸ | F7 | P08709 | 1/20 | 0.48 |
| ▸ | F3 | P13726 | 1/20 | 0.48 |
| ▸ | PKM | P14618 | 1/20 | 0.48 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.48 |
| ▸ | PARP1 | P09874 | 1/20 | 0.48 |
| ▸ | MAPT | P10636 | 1/20 | 0.48 |
| ▸ | PMP22 | Q01453 | 1/20 | 0.48 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.48 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.48 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.44 |
| ▸ | PRSS1 | P07477 | 1/20 | 0.44 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL10669214 | 1.00 | BLM (0.48) | BLMRECQLTSHRTDP1POLB | |
| SCHEMBL19159184 | 0.80 | TDP1 (0.41) | BLMRECQLTSHRTDP1POLB | |
| SCHEMBL6662244 | 0.79 | BLM (0.44) | BLMRECQLTSHRTDP1POLB | |
| SCHEMBL15046255 | 0.79 | BLM (0.44) | BLMRECQLTSHRTDP1POLB | |
| SCHEMBL2396375 | 0.78 | BLM (0.48) | BLMRECQLTSHRTDP1POLB | |
| SCHEMBL12449790 | 0.78 | BLM (0.48) | BLMRECQLTSHRTDP1POLB | |
| SCHEMBL17253723 | 0.78 | BLM (0.48) | BLMRECQLTSHRTDP1POLB | |
| SCHEMBL3471389 | 0.78 | BLM (0.48) | BLMRECQLTSHRTDP1POLB | |
| SCHEMBL16432782 | 0.78 | BLM (0.48) | BLMRECQLTSHRTDP1POLB | |
| SCHEMBL15434763 | 0.77 | CYP3A4 (0.42) | BLMRECQLTSHRTDP1POLB |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2020029846-A1 | RAPID SYNTHESIS METHOD FOR BIOMASS-BASED AMINE COMPOUND | 南京农业大学 | 2020-02-13 | — | — | WO | claimed |
| WO-2020029846-A1 | RAPID SYNTHESIS METHOD FOR BIOMASS-BASED AMINE COMPOUND | 南京农业大学 | 2020-02-13 | — | — | WO | disclosed |
| US-10385013-B2 | Micro/nano materials, products obtained by covalently modifying surface of micro/nano materials with hydrophilic materials, and method for making same | CHONGQING BOLANYING (BLY) BIOTECHNOLOGY CO., LTD. (CN) | 2019-08-20 | — | — | US | disclosed |
| EP-3470443-A1 | MICRO/NANOMATERIAL, PRODUCT THEREOF WITH SURFACE COVALENTLY MODIFIED WITH HYDROPHILIC MATERIAL, AND MANUFACTURING METHOD | Chongqing Bolanying (BLY) Biotechnology Co., Ltd., China (CN) | 2019-04-17 | — | — | EP | disclosed |
| US-20190077746-A1 | MICRO/NANO MATERIALS, PRODUCTS OBTAINED BY COVALENTLY MODIFYING SURFACE OF MICRO/NANO MATERIALS WITH HYDROPHILIC MATERIALS, AND METHOD FOR MAKING SAME | CHONGQING BOLANYING (BLY) BIOTECHNOLOGY CO., LTD. (CN) | 2019-03-14 | — | — | US | disclosed |
| WO-2005058330-A1 | PHOSPHORUS CONTAINING COMPOUNDS USEFUL FOR THE REGULATION OF LDL AND LP(A) LEVELS | QUATRX PHARMACEUTICALS CO. (US) | 2005-06-30 | — | — | WO | disclosed |
| WO-2003106399-A2 | PROCESS FOR PREPARING N-PROTECTED β-AMINO ALDEHYDE COMPOUNDS | THERAVANCE, INC. (US) | 2003-12-24 | — | — | WO | disclosed |
| US-4755599-A | 3-phenyl-2-propeneamine derivatives, their preparation and composition containing them | RHONE-POULENC SANTE (FR) | 1988-07-05 | — | — | US | disclosed |
| US-4686309-A | ANTIDEPRESSANTS | RHONE-POULENC SANTE (FR) | 1987-08-11 | — | — | US | disclosed |
| US-4104383-A | PSYCHOSTIMULANT, ANTISPASMODIC, HYPOTENSIVE, ANALGESIC | C M INDUSTRIES (FR) | 1978-08-01 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20190077746-A1 | MICRO/NANO MATERIALS, PRODUCTS OBTAINED BY COVALENTLY MODIFYING SURFACE OF MICRO/NANO MATERIALS WITH HYDROPHILIC MATERIALS, AND METHOD FOR MAKING SAME | PHOSPHO1, PTMS, PAM | BLM 3573/4885RECQL 4225/4885TSHR 2276/4885 |
| US-10385013-B2 | Micro/nano materials, products obtained by covalently modifying surface of micro/nano materials with hydrophilic materials, and method for making same | PHOSPHO1, PTMS, PAM | BLM 3573/4885RECQL 4225/4885TSHR 2276/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.